Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Bydureon
.
Show all posts
Showing posts with label
Bydureon
.
Show all posts
Tuesday, August 14, 2012
Amylin, Alkermes announce results from BYDUREON clinical study on type 2 diabetes
›
In continuation of my update on Bydureon We know that, Exenatide (marketed as Byetta , Bydureon see structure ) is a medication a...
Sunday, January 29, 2012
FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes
›
In continuation of my up date on Exenatide... Amylin Pharmaceuticals, Inc. and Alkermes plc today announced that the U.S. Food and Drug ...
1 comment:
›
Home
View web version
